Scientists test Drug's path to the brain in fight against recurrent tumors
NCT ID NCT02933736
Summary
This study is testing whether an oral cancer drug called ribociclib can get into the brain and reach recurrent brain tumors. It involves 48 adults with recurrent high-grade glioma or meningioma who are scheduled for surgery. Patients take the drug for a short time before their operation so researchers can measure drug levels in the removed tumor tissue and spinal fluid.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barrow Brain and Spine
Phoenix, Arizona, 85013, United States
Conditions
Explore the condition pages connected to this study.